Jove
Visualize
Contact Us

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

162
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
162
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

180
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

160
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
160
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

137
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
137
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

130
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
130
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

187
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
187

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Can Technology Simplify Aging Care-or Just Shift the Complexity?

The Senior care pharmacist·2026
Same author

Comprehensive Geriatric Assessment and Medication "Appropriateness".

The Senior care pharmacist·2026
Same author

Factors Associated with Healthcare Utilization in Children with Sickle Cell Disease in Saudi Arabia.

International journal of environmental research and public health·2026
Same author

Caring for the Caregiver.

The Senior care pharmacist·2026
Same author

Reflecting on the Value of Mentors.

The Senior care pharmacist·2026
Same author

Navigating the New F-605: Collaboration and Compliance in Psychotropic Medication Use.

The Senior care pharmacist·2025
Same journal

Transitioning Medication-Related Home Visits to a Cognitively Accessible Digital Intervention in Home Care: A Practice Innovation Pilot.

The Senior care pharmacist·2026
Same journal

Perception of Technology to Support Medication Management Among Community-dwelling African American Older Adults.

The Senior care pharmacist·2026
Same journal

ASCP Policy Review Committee.

The Senior care pharmacist·2026
Same journal

Initial Evaluation of L-mMRC Severity Tool in Staging COPD in the Skilled Nursing Setting.

The Senior care pharmacist·2026
Same journal

Dispense This: How AI Is Reshaping Pharmacy's Clinical Services.

The Senior care pharmacist·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 23, 2025

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

2.3K

Geriatric Pharmacotherapy Case Series: Overactive Bladder.

Demetra Antimisiaris, Kristina Niehoff

    The Senior Care Pharmacist
    |April 29, 2020
    PubMed
    Summary
    This summary is machine-generated.

    This case study examines overactive bladder (OAB) treatment in older adults. It highlights a unique OAB presentation and outlines a strategic approach for patient case analysis and management.

    More Related Videos

    Real-Time Void Spot Assay
    06:39

    Real-Time Void Spot Assay

    Published on: February 10, 2023

    2.5K
    Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
    10:19

    Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

    Published on: August 9, 2012

    19.7K

    Related Experiment Videos

    Last Updated: Dec 23, 2025

    Detrusor Underactivity Model in Rats by Conus Medullaris Transection
    03:26

    Detrusor Underactivity Model in Rats by Conus Medullaris Transection

    Published on: August 28, 2020

    2.3K
    Real-Time Void Spot Assay
    06:39

    Real-Time Void Spot Assay

    Published on: February 10, 2023

    2.5K
    Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
    10:19

    Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

    Published on: August 9, 2012

    19.7K

    Area of Science:

    • Geriatric pharmacotherapy
    • Geriatric syndromes
    • Clinical case studies

    Background:

    • Overactive bladder (OAB) is a prevalent geriatric syndrome.
    • OAB is multifactorial, linked to significant morbidity and poor outcomes in the elderly.
    • Managing OAB in older adults requires careful consideration of complex health conditions.

    Purpose of the Study:

    • To review the pharmacotherapy for a patient presenting with overactive bladder (OAB).
    • To illustrate a counterintuitive clinical presentation of OAB in an older adult.
    • To demonstrate a systematic approach to analyzing and planning treatment for geriatric OAB cases.

    Main Methods:

    • Case study methodology.
    • Analysis of a specific geriatric patient's clinical presentation.
    • Pharmacotherapeutic treatment planning for overactive bladder.

    Main Results:

    • The case study details a counterintuitive presentation of OAB in an elderly patient.
    • It outlines the analytical process used to understand the patient's condition.
    • Specific treatment planning strategies are demonstrated.

    Conclusions:

    • Effective management of geriatric OAB requires tailored approaches.
    • Understanding atypical presentations is crucial for successful pharmacotherapy.
    • This case series aims to improve the care of older adults with complex conditions.